Advances in Biomarker Sciences and Technology

Open access

ISSN: 2543-1064

Advances in Biomarker Sciences and Technology

Open access

Editors in Chief

Prof. Luoping Zhang
Prof. Youhe Gao

Editorial Board

Advances in Biomarker Sciences and Technology (ABST) is a rigorously peer-reviewed, fully open access journal that aims to encompass all aspects of biomarker research, from biomarker development to it...

Advances in Biomarker Sciences and Technology (ABST) is a rigorously peer-reviewed, fully open access journal that aims to encompass all aspects of biomarker research, from biomarker development to its applications, clinical diagnosis and treatment to molecular epidemiology and toxicology; from precision medicine to drug development, and from nanotechnology to bioinformatics. ABST focuses on building upon the next generation of biomarkers to accelerate communication of the latest advances in their identification as well as applications. We strive to achieve this objective by providing a high-quality forum for the publication of biomarker-related investigations, including (but not limited to) general research articles elucidating topics in novel technologies, study designs or mathematical models, invited and selected reviews, short communications and editorials.

Editorial Board

Call for Papers

Special Issue on Urine: The Next Generation Biomarker Source

Submission deadline: rolling submission

Special issue on development and advancement of biomarker technologies

Submission deadline: rolling submission

Special Issue on Methods for the Discovery and Validation of Cancer Biomarkers

Submission of papers: rolling submission

View all

News

View all

AI Reads Urine

#AI Reads Urine# Differential Diagnosis and Prognostic Stratification of Testicular Germ Cell Tumors With miRNA from body fluid including urine

#AI Reads Urine# Urine BMP is lowered in frontotemporal dementia due to progranulin mutations

#AI Reads Urine# A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early to late stages: a case control study

View all

Related journals

Stay Informed

Register your interest and receive email alerts tailored to your needs. Sign up below.